Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00559234 · ClinicalTrials.gov registry record

Potential Research Participants for Future Studies of Inherited Eye Diseases

A clinical trial, sponsored by National Eye Institute (NEI).

Completed
Registry status
400
Enrollment target

NCT00559234: Completed study, sponsored by National Eye Institute (NEI).

NCT00559234 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00559234 has completed, sponsored by National Eye Institute (NEI).

COMPLETED
Registry status
400 participants
Enrollment target

Study Summary

This study will evaluate potential candidates for future clinical research studies related to diagnosed or undiagnosed genetic eye disorders or diseases. It will not test any new treatments, but it may arrange for standard treatments for existing eye disorders. The purpose of the study is to train eye doctors and medical researchers at the National Institutes of Health in appropriate methods and procedures for treating patients with genetic eye diseases, and to expand the pool of possible participants for future research studies and trials on eye health. Volunteers for this study may be adults and minor children who have been diagnosed with or are at risk for having a genetic eye disease. Candidates may not have any other medical conditions that would interfere with the researchers' ability to perform the examinations and procedures required for this study. Participants will give a complete medical and family history and undergo a series of tests and procedures as part of this research study. The procedures include a full eye examination and vision testing, electrooculography and an electroretinogram to examine the function of the retina, and flourescein angiography to provide information on the flow of blood in the participant's eyes. Participants will provide research material for further studies by giving a blood sample to be held for genetic testing and analysis, and adult participants will also undergo a skin biopsy to provide cell tissue for additional research material. At each clinic visit, participants will receive treatment for their genetic eye disease as needed, including medications or surgical procedures. Participants may remain a part of this study for up to three years.

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2007-11-09
Est. Completion 2008-10-03
National Eye Institute (NEI)

221 total trials

What the finished NCT00559234 record still lists

NCT00559234 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00559234 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00559234 about?

NCT00559234 is a clinical study titled "Potential Research Participants for Future Studies of Inherited Eye Diseases". This study will evaluate potential candidates for future clinical research studies related to diagnosed or undiagnosed genetic eye disorders or diseases. It will not test any new treatments, but it may arrange for standard treatments for existing eye disorders. The purpose of the study is to train e...

What is the current status of trial NCT00559234?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2007-11-09. Estimated completion is 2008-10-03.

Who is sponsoring clinical trial NCT00559234?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00559234, the US trial registry maintained by the National Library of Medicine. NCT00559234 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.